(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.

Julia HöflerAlexandra RohracherGudrun KalssGeorg ZimmermannJudith DobesbergerGeorg PilzMarkus LeitingerGiorgi KuchukhidzeKevin ButzAlexandra TaylorHelmut NovakEugen Trinka

Published in: CNS drugs (2018)

Treatment of SRSE in adult patients with (S)-KET led to resolution of status in 64 %. No adverse events were found, indicating a favorable safety profile.

Keyphrases

single molecule
combination therapy
replacement therapy
smoking cessation